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The main aim of the study was to identify predictors of the eﬀects of lifestyle intervention on diabetes mellitus type 2 patients
by means of multivariate analysis. Data from a previously published randomised clinical trial, which compared the eﬀects of a
rehabilitation programme including standardised education and physical training sessions in the municipality’s health care centre
with the same duration of individual counseling in the diabetes outpatient clinic, were used. Data from 143 diabetes patients were
analysed. The merged lifestyle intervention resulted in statistically signiﬁcant improvements in patients’ systolic blood pressure,
waist circumference, exercise capacity, glycaemic control, and some aspects of general health-related quality of life. The linear
multivariateregressionmodelsexplained45%to80%ofthevarianceintheseimprovements.Thebaselineoutcomesinaccordance
to the logic of the regression to the mean phenomenon were the only statistically signiﬁcant and robust predictors in all regression
models. These results are important from a clinical point of view as they highlight the more urgent need for and better outcomes
following lifestyle intervention for those patients who have worse general and disease-speciﬁc health.
1.Background
Diabetes mellitus type 2 (DM2) is a metabolic disorder
that is characterised by high blood glucose in the context
of insulin resistance and relative insulin deﬁciency. Severe
complications can result from improperly managed DM2,
including renal failure, blindness, slow healing of wounds,
cardiovascular diseases, and erectile dysfunction. Changes
in lifestyle, such as reduced physical activity, an unhealthy
diet, and subsequent obesity, are the main causes of DM2.
Systematic dietary treatment and/or exercise programmes
have been shown to halve the risk of the development of
DM2, as well as to lower blood sugar in diabetic patients [1].
The prevalence of DM2 is increasing in many countries
including Denmark [2]. According to the Danish National
Diabetes register, the number of patients diagnosed with
diabetes (both types) in 2007 was 240,000, corresponding to
about 4,000 diabetics per 100,000 Danes. In addition, many
people with DM2 are thought to be undiagnosed [3].
The Integrated Rehabilitation for Chronic Conditions
Project (SIKS) implemented lifestyle intervention pro-
grammes for people with chronic conditions, including
DM2,withinCopenhagen.Theinterventionwasarehabilita-
tionprogrammeincludingeducationalsessionsorindividual
counselling,physicaltraining,dietaryinstruction,andsmok-
ingcessationsessions.Thedevelopmentandimplementation
of the intervention took place from April 2005 to September
2007, was funded by the Ministry of Interior and Health,
and involved cooperation between three organisations rep-
resenting diﬀerent sectors within the Danish health care
system: (1) Bispebjerg Hospital (secondary health care; in
general, responsibility for the administrative regions), (2)
the municipality of Copenhagen (rehabilitation; in general,
responsibility for the administrative municipalities), and (3)
general practitioners (GPs) (primary health care and “gate
keeping,” in general, private practice reimbursed by the
administrative regions). The project was evaluated in terms2 The Scientiﬁc World Journal
of organisation, processes, and patient outcomes using both
qualitative and quantitative measures [4, 5].
A detailed description of the evaluation of the interven-
tion on DM2 patients can be found in Vadstrup, 2010 [6–
8]. In brief, it was a randomised clinical trial comparing a
rehabilitation programme, including standardised education
and physical training sessions in the municipality’s health
care centre, and an equally long period of individual coun-
seling in the diabetes outpatient clinic. The main ﬁnding was
that the mean glycosylated hemoglobin (HbA1c) decreased
signiﬁcantly more among participants in the individual
counseling group compared to the standardised rehabili-
tation programme. Both interventions similarly improved
patients’ weight, waist circumference, blood pressure, and
some aspect of health-related quality of life.
2. Purpose
The main aim of this study was to explore which patient
and/or treatment characteristics had an impact on the
merged lifestyle intervention (i.e., in the municipality’s
health care centre and in the diabetes outpatient clinic)
eﬀect while distinguishing variables related to intervention
organisation (i.e., health care centre versus diabetes outpa-
tient clinic), diabetes care processes (i.e., urine, eye, and feet
checks),andpatients’healthoutcomes(i.e.,resultsofgeneral
and disease-speciﬁc health and health-related quality of life
assessments).
3. Methods
3.1. Assessments. A detailed description of the measures
used to describe the patient sample before and after the
intervention can be found in Vadstrup, 2010 [7]. Table 1
brieﬂy presents the tests/questionnaires taken/responded to
by DM2 patients to assess their health and quality of life; a
more detailed description of some of the tests/questionnaires
used follows.
6-Minute Walk Test. Patients above 60 years of age per-
formed this test in an unobstructed indoor corridor. They
walked25metresfromoneendofthecorridortotheotherat
their own pace as many times as possible in 6min. The total
distancewalkedwasmeasuredinmeters.Thetestisafeasible,
reliable, and valid measure of functional capacity targeted
at older people and people with moderate-to-severe physical
impairment [9, 10]. (Patients under 60 years old underwent
a cycling test, but the number of these patients was so small
that they were not included in the analyses).
SFT st and SFT 2.45. During the SFT st, the patient had
to sit on a regular chair without armrests and stand up as
manytimesaspossiblein30seconds.TheSFT2.45measured
the time in seconds that a person required to rise from a
regular chair without armrests, walk around a cone that was
located 2.45 meters away, go back to the chair, and sit down
again. Both tests have been proven to be valid and reliable in
multiple studies [11].
Table 1: Pre- and postintervention measurements among DM2
patients.
Subject of
assessment
Tests and instruments used for
assessment
General health
Weight, body mass index (BMI), waist
circumference, systolic blood pressure
(BP systolic), and diastolic blood
pressure (BP diastolic)
General
functioning
6-minute walk test, stand and sit
standard senior ﬁtness test (SFT st),
and 2.45-minute up and go senior
ﬁtness test (SFT 2.45)
Disease-speciﬁc
functioning
Glycosylated hemoglobin (HbA1c),
cholesterol, high-density lipoproteins
(HDL), low-density lipoproteins
(LDL), and triglycerides
General and
disease-speciﬁc
health-related
quality of life
Short form 36 (SF 36), diabetes
symptom checklist-revised (DSC-R)
SF 36. This is a valid and reliable questionnaire that has
been used extensively in many languages. The SF 36 is a
multipurpose health survey comprising 36 questions that
measure eight domains: physical function, physical limita-
tion, bodily pain, general health, vitality, social function,
emotional limitation, and mental health. The ﬁrst four
domains can be merged into a summary Physical SF 36 (PSF
36), while the rest can be merged into the summary Mental
SF 36 domain (MSF 36). The raw scores in each domain
are transformed into 0 to 100 scales, with higher scores
indicating superior quality of the relevant aspects of health-
related quality of life. The scale has repeatedly shown high
reliability and validity in multiple studies in many languages,
including Danish [12].
DSC-R. This is a diabetes-speciﬁc questionnaire measuring
the occurrence and perceived burden of diabetes-related
symptoms in a broad comprehensive manner. It consists of
34 questions, which can be grouped into eight subscales. The
total score ranges from 0 to 5 and is calculated by summing
the item scores and dividing the sum by the number of
items. A reduction in the score indicates an improvement
in psychological and physiological distress. The DSC-R is
known to be valid, reliable, and responsive to change [13].
3.2. Statistical Analyses. Uni- and bivariate analyses were
used to describe the sample at baseline. Paired t-tests were
used to identify the signiﬁcant intervention-related changes
or merged lifestyle intervention eﬀects [14]. Multivariate
linear regression models wererunto explain the intervention
eﬀects, where statistically signiﬁcant diﬀerences between
pre- and postintervention outcomes were the dependent
variables, and demographic characteristics, preintervention
(i.e., baseline) outcomes, engagement with intervention,
intervention-providing unit, and other intervention-relatedThe Scientiﬁc World Journal 3
changes of statistical signiﬁcance were entered as indepen-
dent variables. To test the sensitivity of the results, analyses
were conducted with complete data sets (i.e., replacing
missing data with the means) [15]. SPSS 18.00 was used for
all analyses.
4. Results
4.1. Sample. Measurements were taken from 143 diabetes
patients at baseline (Table 2). Slightly more than half of
the patients were males; the majority were of working age;
33.6% lived alone. The majority had a healthy lifestyle
in terms of alcohol units consumed and time spent on
exercise; 19.6% currently smoked. The results of the tests
on exercise capacity were within the normal limits, with
the exception of SFT 2.45, for which mean (SD) was 5.2
(4.42), the norm being 7–10 [11]. On average, patients
were obese; mean BMI (SD) was 32.5 (6.27), the norm
being up to 25 [16]. The BMI was signiﬁcantly higher
among women. On average, patients had mild hypertension;
mean systolic/diastolic blood pressure (SD) was 147.7/84.7
(17.36/9.62), the norm being less than 130/80mmHg [17].
Some of the disease-speciﬁc outcomes, such as glycaemic
control (HbA1c treatment norm being up to 6.1% [17]),
cholesterol (treatment norm being up to 4.5mmol/L [17]),
and LDL (treatment norm being up to 2.5mmol/L [17])
were in the normal limits; however, HDL levels were lower
(treatment norm being from 1.2mmol/L for women, and
from 1.7mmol/L for men [17]) and triglycerides (treatment
norm being up to 1.7mmol/L [17]) were higher than the
norm, indicating a slightly increased cardiovascular risk in
the sample [18]. The scores on the general health-related
quality of life questionnaire (SF 36) in the study population
were close to those of healthy Danes aged 55–64 years [12].
The mean (SD) score on the diabetes-speciﬁc quality of life
questionnaire (DSC-R) was 0.9 (0.64), which corresponded
well with the mean score of this measure among diabetes
patients with a BMI ranging from 30.0 to 39.9 [19]. The
duration of diabetes in the sample was up to 10 years. The
majority of patients were being monitored by their general
practitioners (GPs) and more than half had had eye, feet, or
urine checks during the past year.
The results of bivariate analyses of baseline outcomes
were as follows: (a) older age correlated with decreased exer-
cise capacity; (b) within the cardiovascular risk indicators,
cholesterolwasdirectlyrelatedtoLDL,andtriglycerideswere
inversely related to HDL; (c) BMI, blood pressure, HbAc1,
and cardiovascular risk symptoms such as cholesterol, LDL,
and triglycerides were mutually intercorrelated; (d) the
outcomes from the diﬀerent exercise capacity measures
were mutually interrelated; (e) worse exercise capacity was
associated with higher BMI and lower scores on SF 36—the
emotional functioning subscale. In addition, patients who
had had their eyes and feet checked during the past year had
had diabetes for a longer time; and those who had had their
feet checked during the past year had had signiﬁcantly worse
results in the exercise capacity tests as well as lower scores SF
36—the physical functioning and the bodily pain subscales.
4.2. Eﬀects of the Intervention. Out of 143 patients, 53
(37.1%) completed the intervention programmes (i.e., com-
plied with more than half of the prescribed rehabilitation
activities). Table 3 shows the statistically signiﬁcant eﬀects of
themergedinterventioncalculatedasthediﬀerencesbetween
post- and preintervention measurements.
In accordance with previously published reports [7],
the intervention resulted in statistically signiﬁcant improve-
ments in DM2 patients’ systolic blood pressure, waist
circumference, exercise capacity, glycaemic control (HbA1c),
and some aspects of general health-related quality of life.
4.3. Predictors of the Intervention Eﬀects. Table 4 presents
the results of the linear hierarchical regression models, in
which the following independent variables were included:
(1) sociodemographic characteristics: age and gender, (2)
baseline outcomes: alcohol units, exercise hours, waist
circumference, systolic blood pressure, one of the exercise
capacity test results, SF 36—general health and SF 36—
vitality scores for analogous SF 36 changes and MSF 36 for
all other changes, logarithm (lg) to normalise distribution
of disease duration, and eye-foot-urine checks, (3) unit in
which the intervention took place, (4) completion of the
intervention, and (5) other intervention-related changes of
statistical signiﬁcance forward inclusion. To better interpret
the results, the outcome variables were standardised to give
a positive value, that is, in cases in which the changes were
negative (e.g., blood pressure had decreased), these changes
were multiplied by (−1).
The regression model explained more than 60% of
the change in systolic blood pressure. The baseline value
(higher blood pressure at baseline-larger change) was the
only signiﬁcant and robust predictor in the model. Similar
results were obtained from the model for the change in
waist circumference. The models explained from 50% to
almost 80% of the variance in the case of changes in exercise
capacity, and the baseline values (worse exercise capac-
ity at baseline-larger change) were signiﬁcant and robust
predictors in the models; additionally, disease duration
negatively (longer disease-smaller change) and intervention
unit (intervention in a health care centre, where exercise
training was included in the programme-larger change)
positively predicted the change in SFT st. The model for
the change in glycaemic control (HbAc1) explained almost
60% of the variance, and the baseline value (higher HbAc1 at
baseline-larger change) was the only signiﬁcant and robust
predictor. Similarly, the model for the change in cholesterol
level predicted almost 70% of the variance, with the baseline
value (higher cholesterol at baseline-larger change) being the
only signiﬁcant and robust predictor. The models for the
changes in the two health-related quality of life dimensions
explained 45% to 80% of the variances, with baseline values
being signiﬁcant and robust predictors in both models.
5. Discussion
The aim of this study was to determine which baseline health
and health-related quality of life characteristics as well as4 The Scientiﬁc World Journal
Table 2: Sample characteristics before intervention (N = 143).
Group of variables Variable Outcomes in means (SD)∗ or %
Gender
Men 59.4
Women 40.6
Age 58.2 (9.65)
Ethnicity
Danes 90.9
Other nationalities 9.1
Civil status
Sociodemography With partner 66.4
Alone 33.6
Job situation
In job 39.9
Out of job 7.0
Retired 53.1
Education
High school/special technical 44.8
Grammar school/university 55.2
Alcohol units per week Median 2.0 (IQR 1.0–7.0)
Smoking status
Smokers 19.6
Lifestyle Never smokers 36.4
Quit smokers 44.0
Median 6.5
Exercising hours per week (IQR 4.0–11.8)
BMI 32.5 (6.27)
General health Waist circumference 108.8 (14.90)
Blood pressure systolic/diastolic 147.7/84.7 (17.36/9.62)
6-minute walk test in meters (N = 68) 524.8 (112.54)
General functioning SFT st in times per 30 seconds 16.1 (4.28)
SFT 2.45 in seconds 5.2 (1.42)
HbA1c in % 7.9 (0.84)
Cholesterol in mmol/L 4.8 (1.05)
Disease-speciﬁc functioning LDL in mmol/L 2.7 (0.95)
HDL in mmol/L 1.2 (0.34)
Triglycerides in mmol/L 2.3 (1.52)
SF 36—physical functioning 80.6 (19.98)
SF 36—physical role functioning 72.5 (35.82)
SF 36—bodily pain 80.0 (23.78)
SF 36—general health perception 64.0 (19.67)
SF 36—vitality 60.0 (23.64)
General and disease-speciﬁc health-related quality of life SF 36—social role functioning 87.5 (21.13)
SF 36—emotional role functioning 75.90 (35.85)
SF 36—mental health 78.0 (18.70)
SF 36—physical component merged 74.9 (19.76)
SF 36—mental component merged 75.1 (20.72)
DSC-R 1.0 (0.62)
Health care professional taking care of diabetes
General practitioner 74.8
Endocrinologist 25.2
History of the disease and its treatment Length of diabetes in years 6.6 (6.43)
Having eye check in the past year 64.3The Scientiﬁc World Journal 5
Table 2: Continued.
Group of variables Variable Outcomes in means (SD)∗ or %
Having foot check in the past year 63.6
Having urine check in the past year 67.8
Abbreviations: N: sample size; SD: standard deviation, unless otherwise indicated; IQR: interquartile range for not normally distributed outcomes.
Table 3: Statistically signiﬁcant eﬀects of the merged lifestyle intervention.
Group of variables Variable Pre-post diﬀerence mean [SE] (N)
General health Waist circumference in cm −3.8 [1.96]∗ (121)
Blood pressure systolic in mm Hg −5.2 [1.27]∗ (121)
General functioning SFT st in times per 30 seconds 2.05 [0.65]∗ (95)
SFT 2.45 in seconds −0.4 [0.19]∗ (95)
Disease-speciﬁc functioning HbAc1 in % −0.5 [10.12]∗∗ (117)
Cholesterol in mmol/L −0.3 [0.13]∗ (121)
General and disease-speciﬁc health-related quality of life SF 36—general health perception 4.3 [1.97]∗ (97)
SF 36—vitality 6.3 [2.80]∗ (95)
∗P<0.05; ∗∗P<0.001, SE: standard error of the mean, N: sample size.
diabetes care process-related variables (such as eye, foot,
and urine checks), together with intervention-related vari-
ables (such as intervention-providing unit and engagement
with intervention), predicted lifestyle intervention-related
changes among DM2 patients. The results of multivariate
linear regression models indicated that the relevant baseline
outcomes were the largest and only statistically signiﬁcant
and robust predictors for all intervention eﬀects, that is,
pre- and postintervention changes in blood pressure, waist
circumference, HbAc1, exercise capacity, and some aspects
of general health-related quality of life.
The baseline characteristics of DM2 patients entering the
intervention, the intervention eﬀects and their predictors,
and the validity of the study will be discussed in more detail
below.
5.1.StudyPopulation. AsdescribedintheResultssection,the
study population comprised relatively healthy middle-aged
Danes, who had been diagnosed with DM2 and on average
were slightly obese and had mild hypertension as well as
mildly increased cardiovascular risk. In terms of the general
functioning and quality of life outcomes, the only diﬀerence
fromhealthyDanesofsimilaragewasaslightlylowerexercise
capacity, which was anticipated given that a decrease in
exercise capacity is usually related to increased body mass
[20, 21]. Disease-speciﬁc functioning and quality of life out-
comes corresponded well with analogous outcomes among
DM2 patients with a similar body mass [19]. The results of
bivariate analyses of baseline outcomes (i.e., reduced exercise
capacity among older patients; mutual association between
glycaemic control, BMI, and cardiovascular risk indicators,
such as blood pressure and lipid proﬁle; correlation between
exercise capacity and mental quality of life component)
were consistent with ﬁndings/conventions reported in the
literature [21–28]. Additionally, the patients, who had had
their eyes and feet checked during the past year, had been
diagnosed with DM2 for longer and were less physically
ﬁt, and had lower scores on the quality of life survey’s
subscales addressing issues related to physical health. We
suggest that the more frequent eye and feet checks in the
study sample indicated more severe disease rather than
better quality of diabetes care process. According to the
literature, patients participating in rehabilitation activities
are more motivated to change their health status [29]. Thus,
all patients who volunteered to participate in the life-style
intervention analysed most probably took good care of
themselves, and therefore those who were/felt more ill came
to eye and feet checks more frequently comparing to those
who were/felt less ill.
5.2. Intervention Eﬀects and Their Predictors. The eﬀects of
lifestyle interventions on DM2 patients are relatively well
described in the literature and the eﬀects seen in this study
corresponded well with those described previously [30–
33]. However, few studies have attempted to explain these
eﬀects using multivariate analysis. We screened the PubMed
abstracts of the past 10 years, which we retrieved using
the following combination of keywords: diabetes mellitus
type 2, rehabilitation/exercising/education, and multivariate
analysis/regression, and we identiﬁed only a few studies
[34–38]. The vast majority of these studies focused on the
multivariate explanation of the eﬀect of exercise training on
glycaemic control, and one of them looked at the eﬀect of
training on cardiovascular risk indicators [37].
Thus, our study contributes to the literature by present-
ing multivariate analyses of the eﬀects of more comprehen-
sive lifestyle intervention on DM2 patients in general and
on exercise capacity and quality of life in particular. The
latter will be touched upon later. With regard to exercise
capacity, it was shown that changes in exercise capacity
were dependent on the duration of disease, which, in turn,
might have been related to age. Study participants who
had had DM2 for a longer period (and who were probably
older) showed less improvement in their exercise capacity6 The Scientiﬁc World Journal
Table 4: Parameters of the multivariable linear regression models to explain intervention eﬀects.
Group of variables Dependent variables Adjusted R square
%( N)
Statistically signiﬁcant predictors:
standardized coeﬃcient beta
General health
Blood pressure
systolic change
(multiplied by (−1))
61.4∗∗ (61) Blood pressure systolic baseline: 0.754∗∗
Exercising baseline◦: 0.266∗
Waist circumference
change (multiplied by
(−1))
61.2∗∗ (66) Waist circumference baseline: 0.745∗∗
Blood pressure systolic change◦: 0.420∗
General
functioning
SFT st change 51.3∗ (65)
SFT st baseline: −0.607∗∗
Lg disease length: −0.296∗
Unit1: 0.349∗
SFT 2.45 change
(multiplied by (−1)) 77.3∗ (61) SFT 2.45 baseline: 0.777∗∗
Blood pressure systolic baseline◦: 0.285∗
Disease-speciﬁc
functioning
HbAc1 change
(multiplied by (−1)) 59.7∗ (61)
HgbAc1 baseline: 0.610∗∗ Completion of
intervention2◦: 0.181∗
BP systolic change (multiplied by (−1))◦:
0.377∗ Cholesterol change (multiplied by
(−1))◦: 0.459∗
Cholesterol change
(multiplied by (−1)) 67.6∗ (61) Cholesterol baseline: 0.925∗∗
Lg disease length◦: 0.198∗
General
health-related
quality of life
SF 36 general health
change 45.5∗∗ (64)
SF 36—general health baseline: −0.731∗∗
Alcohol units baseline◦: −0.293∗
Waist circumference baseline◦: 0.366∗
SF 36 vitality change 79.8∗∗ (65) SF 36—vitality baseline: −0.754∗∗
1: reference group: outpatient clinic; 2: reference group: those who did not complete the intervention; ∗: P<0.05; ∗∗: P<0.001, ◦: sensitive to missing data
imputation.
than those patients who had been diagnosed with DM2
recently (and who were probably younger). Older age was
previously reported to be related to a lower exercise capacity
in DM2 patients [21]. Our results additionally showed
that older patients are not only physically weaker but also
exhibit smaller improvements in their physical ﬁtness during
lifestyle interventions. Changes in exercise capacity were also
predicted by the unit, in which the intervention took place.
Changes were greater among those patients who attended
a health care centre for the intervention, where, unlike
the individually counselled patients, they also participated
in a physical training programme. Thus, physical training
certainly has an impact on changes in exercise capacity
among DM2 patients as well as other patients with chronic
condition [39].
With regard to the change in glycaemic control and
cardiovascular risk (i.e., blood pressure and lipid proﬁle),
our data conﬁrmed previous ﬁndings. For example, the
results of our study, as well as those of previously conducted
studies, showed that the change in HbA1c was dependent
on whether the patients completed all the rehabilitation
activities including exercise training or not [34, 35], and that
the larger changes in HbA1c were related to higher levels of
HbAc1 at the start of the intervention [38].
In conclusion, our study clearly shows that when pre-
dicting the eﬀects of lifestyle intervention on DM2 patients
by means of multivariate linear regression models, the
largest in size and only statistically signiﬁcant and robust
predictors of all intervention-related changes are variables
evidencing what is generally known as “regression to the
mean” phenomenon. In statistics, “regression to the mean”
is the phenomenon that if a variable is extreme on its ﬁrst
measurement, it will tend to be closer to the average on
a second measurement, and if it is extreme on a second
measurement, it will tend to have been closer to the average
on the ﬁrst measurement. In our study, that is, the poorer
selected variables at baseline, the larger the improvement of
these outcomes following the rehabilitation. Such a result,
though had been expected statistically, is still important
from a clinical point of view. It highlights the urgent need
for and better outcome of lifestyle interventions for those
DM2 patients who are physically weak, have poor glycaemic
control and high cardiovascular risk, and assess their general
health-related quality of life as being poorer. Regarding the
latter, the results showed that only a couple of SF 36 survey
subscales, namely, general health and vitality, improved
signiﬁcantly after the intervention. It is relatively common
that DM2 patients’ general health-related quality of life is
fairly similar to the one among healthy people of a similar
age, which was also the case in our study [40, 41]. Therefore,
following the previously outlined logic of regression to the
mean, small and not signiﬁcant changes in the rehabilitated
patients’ SF 36 outcomes could have been anticipated.
5.3. Validity of the Study. The arguments supporting validity
of the study were that only well-known, valid, reliable, and
feasiblemeasureswereusedtoassesspatientoutcomesbefore
and after the intervention. Moreover, some constructs, suchThe Scientiﬁc World Journal 7
as exercise capacity, were assessed by several tests. The fact
that the descriptive characteristics of the study population
were similar to those of other populations described pre-
viously conﬁrms the validity of the descriptive results. The
limitations, however, include a possible selection bias as the
patients entered the intervention voluntarily. Moreover, due
to the absence of standardised recording and the relatively
small sample size, we did not account for other important
predictors which could inﬂuence the results, for example,
comorbidities as well as antidiabetic, antihypertensive, and
lipid-lowering therapy changes during the study [42].
Finally, the study was not speciﬁcally designed to exam-
ine the investigated problems; we used previously collected
data to determine whether the eﬀect of a newly introduced
rehabilitation programme in the municipality’s health care
centre would diﬀer from that of individual counselling
carried out for the same length of time in the diabetes out-
patient clinic. As the eﬀects of the interventions performed
in these two health care facilities did not diﬀer to any great
extend, the data were merged to increase the sample size
and thus to improve the statistical power of the multivariable
analyses.
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